Document is current
Any future updates will be listed below
-
Authors
Hemilä, Harri https://orcid.org/0000-0002-4710-307X
de Man, Angelique M.E. https://orcid.org/0000-0001-8738-8295
-
Funding
Funding for this research was provided by:
University of Helsinki
- License Information
-
More Information
Article History
Received: 22 October 2023
Accepted: 1 March 2024
First Online: 19 March 2024
Declarations
:
: This is a secondary analysis, not applicable.
: Not applicable.
: H. Hemilä declares no potential conflicts of interest with respect to the research, authorship and/or publication of this article. A.M.E. de Man is coauthor of the LOVIT-COVID/REMAP-CAP trial [] and received funding from the Netherlands Organisation for Health Research and Development for an RCT investigating high-dose vitamin C post-cardiac arrest, see doi: .
